Powder: -20°C for 3 years
In solvent: -80°C for 2 years
LX-1031 is an effective inhibitor of tryptophan 5-hydroxylase. LX-1031 decreases serotonin (5-HT) synthesis peripherally.
Description | LX-1031 is an effective inhibitor of tryptophan 5-hydroxylase. LX-1031 decreases serotonin (5-HT) synthesis peripherally. |
In vivo | LX-1031 reduces the expression of 5-HT in the duodenum, jejunum, and ileum in a dose-dependent manner, but has no effect on brain 5-HT levels in preclinical assay[1]. The average 5-HT reductions in the jejunum relative to control are appr 33, 51, and 66% |
Molecular Weight | 538.52 |
Formula | C28H25F3N4O4 |
CAS No. | 945976-76-1 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 30mg/mL (55.71 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LX-1031 945976-76-1 G蛋白偶联受体 代谢 LPA Receptor Hydroxylase inhibit Inhibitor LX1031 LX 1031 Tryptophan Hydroxylase inhibitor